These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8537751)

  • 21. Hawthorn extract improves chronic heart failure.
    Eaton LJ; Kinkade S
    J Fam Pract; 2003 Oct; 52(10):753-4. PubMed ID: 14529593
    [No Abstract]   [Full Text] [Related]  

  • 22. Oral milrinone in severe chronic heart failure.
    Desjardins S
    N Engl J Med; 1992 Jun; 326(23):1565; author reply 1567. PubMed ID: 1579141
    [No Abstract]   [Full Text] [Related]  

  • 23. [Inotropic drugs in treatment of heart failure--advantages and adverse reactions].
    Witkowska M
    Pol Tyg Lek; 1992 Oct 5-12; 47(40-41):936-40. PubMed ID: 1300581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monitored long-term treatment with ibopamine in patients suffering from severe congestive heart failure.
    Avanzini Z; Bellogini GC; Brusoni B; Ciampani N; Dei Cas L; Gazzola U; Maggi GC; Mangiavacchi M; Metra M; Pinca L
    Arzneimittelforschung; 1986 Feb; 36(2A):394-7. PubMed ID: 3707656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Digoxin may reduce the mortality rates in patients with congestive heart failure.
    Wang L; Song S
    Med Hypotheses; 2005; 64(1):124-6. PubMed ID: 15533628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistent hemodynamic effects without long-term clinical benefits in response to oral piroximone (MDL 19,205) in patients with congestive heart failure.
    Petein M; Levine TB; Cohn JN
    Circulation; 1986 Mar; 73(3 Pt 2):III230-6. PubMed ID: 3510778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is the efficacy of positive inotropic drugs limited to symptomatic improvement?
    Baumann G; Felix SB
    Herz; 1991 Sep; 16 Spec No 1():304-13. PubMed ID: 1820297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New inotropic-vasodilating drugs in acute and chronic heart failure.
    Goenen MJ
    Ann Med Interne (Paris); 1986; 137(3):229-34. PubMed ID: 3767191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vesnarinone for heart failure.
    Schwartz A; Grupp I; Grupp G
    N Engl J Med; 1994 Jan; 330(1):65; author reply 66. PubMed ID: 8259153
    [No Abstract]   [Full Text] [Related]  

  • 30. [Progress in therapy for chronic heart failure].
    Hori M
    Nihon Naika Gakkai Zasshi; 2002 Mar; 91 Suppl():111-5. PubMed ID: 11989248
    [No Abstract]   [Full Text] [Related]  

  • 31. [Heart insufficiency: current aspects of physiopathology and therapy].
    Bolte HD
    Med Klin; 1981 Nov; 76(24):664-71. PubMed ID: 7311926
    [No Abstract]   [Full Text] [Related]  

  • 32. [Acute and chronic effects of a new oral inotropic agent, ibopamine hydrochloride, on hemodynamic and metabolic responses to ergometer exercise in patients with severe congestive heart failure].
    Morimoto Y; Kasai A; Nagano K; Umino M; Kakuta Y; Iwata J; Hamada M; Konishi T; Nakano T
    Kokyu To Junkan; 1989 Jul; 37(7):773-8. PubMed ID: 2799097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vasodilator therapy for congestive heart failure. Lessons from mortality trials.
    Groden DL
    Arch Intern Med; 1993 Feb; 153(4):445-54. PubMed ID: 8435024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute effects of levosimendan on mitral regurgitation and diastolic function in patients with advanced chronic heart failure.
    Branzi G; Malfatto G; Villani A; Ciambellotti F; Revera M; Giglio A; Rosa FD; Facchini M; Parati G
    J Cardiovasc Med (Hagerstown); 2010 Sep; 11(9):662-8. PubMed ID: 20613551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New aspects for therapy of chronic heart failure with positive inotropic substances].
    Erdmann E
    Verh Dtsch Ges Inn Med; 1991; 97():178-84. PubMed ID: 1808882
    [No Abstract]   [Full Text] [Related]  

  • 36. [Acute and chronic effects of oral cardiotonic agent, denopamine (TA-064) in patients with heart failure].
    Inden M; Yamamuro M; Murayama S; Noda E; Tanimura H; Takasaki H; Konishi T; Nakano T; Takezawa H
    Kokyu To Junkan; 1986 May; 34(5):541-6. PubMed ID: 3738247
    [No Abstract]   [Full Text] [Related]  

  • 37. [Choice for the treatment of congestive heart failure].
    J Cardiol Suppl; 1989; 20():53-6. PubMed ID: 2557870
    [No Abstract]   [Full Text] [Related]  

  • 38. [Ibopamine--clinical results].
    Kleber FX
    Z Kardiol; 1991; 80 Suppl 8():71-6. PubMed ID: 1686695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonglycoside inotropes in congestive heart failure. Are they beneficial or harmful?
    Chatterjee K; Wolfe CL; DeMarco T
    Cardiol Clin; 1994 Feb; 12(1):63-72. PubMed ID: 8181026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapeutic application of atrial natriuretic peptide for congestive heart failure].
    Harada M; Nakao K
    Nihon Rinsho; 2007 May; 65 Suppl 5():115-9. PubMed ID: 17571375
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.